A Prospective, Observational Study of Combination Abiraterone acetate/Enzalutamide Plus Radical Radiotherapy in Patients with Node Positive Non-metastatic Prostate Cancer
Latest Information Update: 24 Mar 2020
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary) ; LHRH receptor agonists; LHRH receptor antagonists; Prednisolone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
Most Recent Events
- 24 Mar 2020 New trial record
- 15 Feb 2020 Interim results (N=13) presented at the 2020 Genitourinary Cancers Symposium